Related Articles
Risk factors for hematological toxicity of chemotherapy for bone and soft tissue sarcoma
Serum ICAM-1 concentrations following conventional dose consolidation chemotherapy for acute myeloid leukemia and after high dose chemotherapy with autologous haematopoietic stem cell rescue.
Prognostic factors in oncological patients with solid tumours requiring intensive care unit admission
Association between the methylation status of the MGMT promoter in bone marrow specimens and chemotherapy outcomes of patients with acute myeloid leukemia
Prediction of docetaxel monotherapy-induced neutropenia based on the monocyte percentage